Tiziana Life Sciences Ltd (TLSA)

Jun 15, 2026

Tiziana Life Sciences Ltd announced that it has received $0.01665 million in funding - marketscreener.com

Jun 15, 2026

Jun 15, 2026

Tiziana Life Sciences (TLSA) Executive Chairman Boosts Stake wit - GuruFocus

Jun 15, 2026

Jun 15, 2026

Tiziana Life Sciences (TLSA) Executive Chairman Boosts Shareholding - GuruFocus

Jun 15, 2026

Jun 15, 2026

Tiziana executive chairman increases stake - Proactive financial news

Jun 15, 2026

Jun 15, 2026

Tiziana Life Sciences Chair Boosts Stake as Foralumab Trials Advance - TipRanks

Jun 15, 2026

Jun 15, 2026

Tiziana Life Sciences Announces Purchase of Shares by Executive Chairman - The Manila Times

Jun 15, 2026

Jun 15, 2026

Tiziana (NASDAQ: TLSA) chair lifts stake with 15,000-share purchase - Stock Titan

Jun 15, 2026

Jun 15, 2026

Founder now owns 34.89% of Tiziana Life Sciences after 15K-share buy - Stock Titan

Jun 15, 2026

May 28, 2026

[6-K] Tiziana Life Sciences Ltd Current Report (Foreign Issuer) | TLSA SEC FilingForm 6-K - Stock Titan

May 28, 2026

May 28, 2026

Tiziana Life Sciences to Present at the Jefferies Global Healthcare Conference in New York - NTB Kommunikasjon

May 28, 2026

May 28, 2026

Tiziana Life Sciences to present clinical updates at Jefferies healthcare conference - Proactive financial news

May 28, 2026

May 28, 2026

Biotech Tiziana to brief investors on clinical updates at Jefferies event - Stock Titan

May 28, 2026

May 27, 2026

Tiziana Life Sciences (TLSA) Slips 2.65% as Stock Tests Key Support ZoneVolume Oscillator - The Legal Advocate

May 27, 2026

May 22, 2026

Tiziana Life Sciences (TLSA) COO discloses Form 3 share and option holdings - Stock Titan

May 22, 2026

May 22, 2026

Tiziana Life Sciences advances foralumab program with full Phase 2 enrollment and encouraging expanded access data – ICYMI - Yahoo! Finance Canada

May 22, 2026

May 21, 2026

Tiziana Life Sciences completes enrollment in Phase 2a trial for multiple sclerosis drug foralumab - Pluang

May 21, 2026

May 21, 2026

Tiziana Life Sciences (TLSA) Completes Patient Enrollment in Cli - GuruFocus

May 21, 2026

May 21, 2026

Tiziana completes enrollment for Phase 2 trial in progressive MS study - Proactive financial news

May 21, 2026

May 21, 2026

Why Is TLSA Stock Rising Today? - Stocktwits

May 21, 2026

May 21, 2026

Tiziana Life Sciences completes enrollment in Phase 2a multiple sclerosis trial - Yahoo! Finance Canada

May 21, 2026

May 21, 2026

Tiziana Fully Enrolls its Phase 2 Placebo Controlled Multiple Sclerosis Trial - The Manila Times

May 21, 2026

May 21, 2026

Phase 2a MS trial fully enrolled at Tiziana Life Sciences (NASDAQ: TLSA) - Stock Titan

May 21, 2026

May 21, 2026

Tiziana Life Sciences (TLSA) Drops 9% as Biotech Sector Volatility WeighsButterfly Setup - The Legal Advocate

May 21, 2026

May 20, 2026

Tiziana Life Sciences Shares Drop After Company Unveils Plan to Spin Out IL-6 Program - MSN

May 20, 2026

May 20, 2026

Tiziana Life Sciences (TLSA) Reports Positive Data on Foralumab for Multiple Sclerosis - GuruFocus

May 20, 2026

May 20, 2026

Updated Clinical Results for Tiziana Life Sciences (TLSA) Show P - GuruFocus

May 20, 2026

May 19, 2026

Tiziana Life Sciences price target boosted on foralumab update - Yahoo! Finance Canada

May 19, 2026

May 19, 2026

Market movers: Amer Sports, Tiziana Life Sciences, Ideal Power, NanoViricides... - Proactive financial news

May 19, 2026

May 19, 2026

Tiziana reports encouraging Expanded Access data for Foralumab in MS patients - Proactive financial news

May 19, 2026

May 19, 2026

Tiziana posts new data for multiple sclerosis drug (TLSA) - Seeking Alpha

May 19, 2026

May 19, 2026

Tiziana Announces New Positive Clinical Data for Intranasal Foralumab in Non-Active Secondary Progressive Multiple Sclerosis - BioSpace

May 19, 2026

May 19, 2026

Tiziana Life Sciences reports encouraging one-year data for intranasal foralumab in progressive MS - Yahoo! Finance Canada

May 19, 2026

May 19, 2026

Intranasal foralumab shows SPMS safety and fatigue gains at Tiziana (Nasdaq: TLSA) - Stock Titan

May 19, 2026

May 19, 2026

About Us - FinancialContent

May 19, 2026

May 14, 2026

Tiziana Brain Trial Draws Fresh Nasdaq Index Attention - Kalkine Media

May 14, 2026

May 14, 2026

Tiziana Life Sciences (TLSA) Reports Positive Early Results in C - GuruFocus

May 14, 2026

May 14, 2026

Small cap wrap: VivoPower, BioHarvest Sciences, Phunware, Tiziana Life Sciences… - Proactive financial news

May 14, 2026

May 14, 2026

Tiziana Reports Reduced Brain Inflammation in Multiple System Atrophy Patients Treated with Intranasal Foralumab - Investing News Network

May 14, 2026

May 14, 2026

Tiziana Life Sciences (TLSA) Reports Positive Early Results in Clinical Trial - GuruFocus

May 14, 2026

May 14, 2026

Tiziana Life Sciences reports brain inflammation reductions in Multiple System Atrophy trial - Yahoo News Canada

May 14, 2026

May 14, 2026

Tiziana reports brain inflammation reduction in MSA trial patients By Investing.com - Investing.com Nigeria

May 14, 2026

May 14, 2026

Tiziana reports brain inflammation reduction in MSA trial patients - Investing.com UK

May 14, 2026

May 14, 2026

Tiziana Life Sciences Posts Early PET Data Showing Reduced Brain Inflammation in MSA Trial of Intranasal Foralumab - TipRanks

May 14, 2026

May 14, 2026

Tiziana Reports Reduced Brain Inflammation In Multiple System Atrophy Patients Treated With Intranasal Foralumab - Mena FN

May 14, 2026

May 14, 2026

Brain inflammation falls in Tiziana (Nasdaq: TLSA) MSA PET trial - Stock Titan

May 14, 2026

May 12, 2026

TradingKey - TradingKey

May 12, 2026

May 11, 2026

TLSA SEC FilingsTiziana Life Sciences Ltd Com 10-K, 10-Q, 8-K Forms - Stock Titan

May 11, 2026